BR0214902A - Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos - Google Patents
Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtosInfo
- Publication number
- BR0214902A BR0214902A BR0214902-8A BR0214902A BR0214902A BR 0214902 A BR0214902 A BR 0214902A BR 0214902 A BR0214902 A BR 0214902A BR 0214902 A BR0214902 A BR 0214902A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- fractions
- bacterial preparation
- bacterial
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
Abstract
"PREPARAçãO BACTERIANA, FRAçõES DE PREPARAçãO BACTERIANA, COMPOSIçãO FARMACêUTICA, USO DA PREPARAçãO BACTERIANA OU SUAS FRAçõES, MéTODO PARA A PRODUçãO DA PREPARAçãO DE BACTéRIAS MORTAS LIOFILIZADAS ESTENDIDAS, KIT PARA O TRATAMENTO DE UMA DOENçA COMPREENDENDO UMA DESREGULAçãO IMUNE, E, PRODUTOS". Composições compreendendo componentes preparados de bactérias Gram positivas, tais como bactérias intracelulares facultativas Gram positivas, por exemplo, micobactérias, incluindo bactérias Gram positivas mortas com liofilização estendida, seu método de preparação e seu uso em humanos e animais, para a prevenção e/ou tratamento de distúrbios compreendendo uma desregulação imune, tal como câncer, doenças autoimunes, alergia e tuberculose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01403195 | 2001-12-11 | ||
| PCT/IB2002/005760 WO2003049752A2 (en) | 2001-12-11 | 2002-12-11 | Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0214902A true BR0214902A (pt) | 2004-11-30 |
Family
ID=8183013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0214902-8A BR0214902A (pt) | 2001-12-11 | 2002-12-11 | Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20060062807A1 (pt) |
| EP (2) | EP1461054B1 (pt) |
| JP (2) | JP4737586B2 (pt) |
| KR (2) | KR101124363B1 (pt) |
| CN (1) | CN1602199B (pt) |
| AT (1) | ATE466585T1 (pt) |
| AU (1) | AU2002356387C1 (pt) |
| BR (1) | BR0214902A (pt) |
| CA (1) | CA2469334C (pt) |
| CY (1) | CY1110727T1 (pt) |
| DE (1) | DE60236318D1 (pt) |
| DK (2) | DK2316466T3 (pt) |
| ES (1) | ES2345188T3 (pt) |
| HK (1) | HK1067073A1 (pt) |
| NZ (2) | NZ555055A (pt) |
| PT (1) | PT1461054E (pt) |
| SI (1) | SI1461054T1 (pt) |
| WO (1) | WO2003049752A2 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0214902A (pt) | 2001-12-11 | 2004-11-30 | Pasteur Institut | Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos |
| WO2004022093A1 (en) * | 2002-09-06 | 2004-03-18 | University College London | Whole bacterial cells as immune modulator |
| ATE473014T1 (de) * | 2003-11-14 | 2010-07-15 | Ucl Business Plc | Immunmodulator mit ganzzell-tsukamurella bakterien |
| EP1730171A1 (en) | 2004-02-19 | 2006-12-13 | Ramot at Tel Aviv University Ltd. | Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| US9107864B2 (en) | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| US8034359B2 (en) | 2004-06-07 | 2011-10-11 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to cancers |
| US8501198B2 (en) | 2004-06-07 | 2013-08-06 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| DK1765391T3 (da) * | 2004-06-07 | 2013-03-25 | Qu Biolog Inc | Bakterielle præparater til behandlingen af cancer |
| WO2006001011A1 (en) | 2004-06-24 | 2006-01-05 | Yissum Research Development Company | Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation |
| CA2531261A1 (en) * | 2005-12-21 | 2007-06-21 | Institut Pasteur | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| NZ576590A (en) * | 2006-10-27 | 2012-08-31 | Qu Biolog Inc | Tissue targeted antigenic activation of the immune response to treat cancers |
| GB0716778D0 (en) * | 2007-08-29 | 2007-10-10 | Bioeos Ltd | Use |
| EP2087898A1 (en) * | 2008-02-06 | 2009-08-12 | Institut Pasteur | A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis |
| CA2629057A1 (en) * | 2008-04-14 | 2009-10-14 | Institut Pasteur | Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria |
| HUP0900231A2 (hu) * | 2009-04-16 | 2010-11-29 | Hyd Rakkutato Es Gyogyszerfejlesztoe Kft | Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására |
| EP2292260A1 (en) | 2009-08-13 | 2011-03-09 | Institut Pasteur | Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis |
| EP2620159A1 (en) | 2012-01-24 | 2013-07-31 | Institut Pasteur | Improved cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria |
| RU2020120075A (ru) | 2014-05-02 | 2020-07-03 | Кью Байолоджикс Инк. | Противомикробная иммуномодуляция |
| CN109414463A (zh) * | 2016-02-25 | 2019-03-01 | 托马斯·朱利叶斯·波洛迪 | 治疗慢性传染性疾病的组合物和方法 |
| CN113226342A (zh) * | 2018-10-17 | 2021-08-06 | 西巴克股份有限公司 | 治疗和预防肺部状况的活的生物治疗剂 |
| JP7441534B2 (ja) * | 2019-01-09 | 2024-03-01 | エムディー ヘルスケア インコーポレイテッド | ロドコッカス属細菌由来ナノ小胞およびその用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2594471A (en) * | 1946-10-11 | 1952-04-29 | Comb Eng Superheater Inc | Heat exchange apparatus |
| GB764718A (en) * | 1954-08-10 | 1957-01-02 | Glaxo Lab Ltd | Improvements in or relating to freeze-drying processes |
| GB1027979A (en) * | 1963-07-12 | 1966-05-04 | Ciba Ltd | Process for obtaining bcg-cultures |
| GB1163470A (en) * | 1967-11-13 | 1969-09-04 | Cecil Arthur Clark | Improvements in or relating to Adjuvant Vaccines |
| JPS57186495A (en) | 1981-05-14 | 1982-11-16 | Ube Ind Ltd | Preparation of l-alpha-methylphenylalanine |
| GB8404280D0 (en) | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
| CA1338879C (en) | 1985-05-13 | 1997-01-28 | Commonwealth Scientific And Industrial Research Organisation | Mastitis vaccine |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| JPS63126830A (ja) * | 1986-11-17 | 1988-05-30 | Isao Moriya | 動植物の体内に抗体を生成する方法 |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| GB9801870D0 (en) * | 1998-01-28 | 1998-03-25 | Raby Limited | Vaccine composition |
| SE9900495D0 (sv) * | 1999-02-12 | 1999-02-12 | Pharmatrix Ab | Vaccine composition |
| US6350457B1 (en) | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| BR0214902A (pt) | 2001-12-11 | 2004-11-30 | Pasteur Institut | Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos |
-
2002
- 2002-12-11 BR BR0214902-8A patent/BR0214902A/pt not_active IP Right Cessation
- 2002-12-11 SI SI200230916T patent/SI1461054T1/sl unknown
- 2002-12-11 EP EP02804652A patent/EP1461054B1/en not_active Expired - Lifetime
- 2002-12-11 KR KR1020117004873A patent/KR101124363B1/ko active IP Right Grant
- 2002-12-11 NZ NZ555055A patent/NZ555055A/en not_active IP Right Cessation
- 2002-12-11 DK DK09075579.4T patent/DK2316466T3/da active
- 2002-12-11 WO PCT/IB2002/005760 patent/WO2003049752A2/en active Application Filing
- 2002-12-11 EP EP09075579.4A patent/EP2316466B1/en not_active Expired - Lifetime
- 2002-12-11 AT AT02804652T patent/ATE466585T1/de active
- 2002-12-11 US US10/497,703 patent/US20060062807A1/en not_active Abandoned
- 2002-12-11 AU AU2002356387A patent/AU2002356387C1/en not_active Ceased
- 2002-12-11 KR KR1020047009081A patent/KR101048798B1/ko not_active IP Right Cessation
- 2002-12-11 DE DE60236318T patent/DE60236318D1/de not_active Expired - Lifetime
- 2002-12-11 NZ NZ533422A patent/NZ533422A/en not_active IP Right Cessation
- 2002-12-11 CN CN028247337A patent/CN1602199B/zh not_active Expired - Fee Related
- 2002-12-11 DK DK02804652.2T patent/DK1461054T3/da active
- 2002-12-11 PT PT02804652T patent/PT1461054E/pt unknown
- 2002-12-11 JP JP2003550801A patent/JP4737586B2/ja not_active Expired - Fee Related
- 2002-12-11 CA CA2469334A patent/CA2469334C/en not_active Expired - Fee Related
- 2002-12-11 ES ES02804652T patent/ES2345188T3/es not_active Expired - Lifetime
-
2005
- 2005-01-21 HK HK05100604.3A patent/HK1067073A1/xx not_active IP Right Cessation
-
2006
- 2006-11-17 US US11/600,907 patent/US7871627B2/en not_active Expired - Fee Related
-
2009
- 2009-10-21 US US12/582,834 patent/US8404250B2/en not_active Expired - Lifetime
-
2010
- 2010-08-04 CY CY20101100731T patent/CY1110727T1/el unknown
-
2011
- 2011-02-03 JP JP2011021856A patent/JP5417354B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0214902A (pt) | Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos | |
| BR0214962A (pt) | Composição para tratar distúrbios neurocerebrovasculares | |
| CY1105221T1 (el) | Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις | |
| ATE375164T1 (de) | Endotoxin-bindung durch milchsäurebakterien und bifidobacteria | |
| WO2004087203A3 (en) | Immunostimulatory nucleic acid oil-in-water formulations for topical application | |
| BR0214705A (pt) | Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit | |
| ITMI20020399A1 (it) | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici | |
| DOP2002000429A (es) | Imidazotriazinas | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| WO2002094228A8 (en) | Prevention and treatment of allergies by helminthic regulation of ige | |
| WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
| EP1783126A3 (en) | N-oxides of N-phenyl-2-pyrimidine-amine derivatives | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| BRPI0416796A (pt) | compostos orgánicos | |
| MXPA06000660A (es) | Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico. | |
| BR0314511A (pt) | Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater | |
| BR0015698A (pt) | Composições e métodos para tratamento de doenças alérgicas | |
| NO20010940D0 (no) | TAN-1057 derivater | |
| MXPA02006511A (es) | Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido. | |
| WO2003024996A3 (de) | Antibakterielle makrozyklen | |
| DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| DE60235418D1 (de) | Osteoprotegerin in Milch | |
| AR045745A1 (es) | Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2 | |
| NO20051159L (no) | Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein | |
| WO2003053959A8 (de) | Heterocyclylaminocarbo nyluracile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |